참고문헌
- 식품의약품안전청 (2008). 생물학적동등성시험기준(제2008-22호)
- Bolton, S. (1991). Outliers-Examples and Opinions, Presented at Bioavailability / Bioequivalence: Phar-macokinetic and Statistical Considerations sponsored by Drug Information Association, Bethesda, Maryland
- Chow, S. C. and Liu, J. P. (2009). Design and Analysis of Bioavailability and Bioequivalence Studies, 3rd Ed., Chapman & Hall/CRC, Florida
- Chow, S. C. and Tse, S. K. (1990). Outlier detection in bioavailability / bioequivalence studies, Statistics in Medicine, 9, 549-558 https://doi.org/10.1002/sim.4780090508
- Clayton, D. and Leslie, A. (1981). The bioavailability of erythromycin stearate versus enteric-coated ery-thromycin base when taken immediately before and after food, Journal of International Medical Re-search, 9, 470-477 https://doi.org/10.1177/030006058100900608
- FDA (2000). Guideline for Industry: Bioavailability and Bioequivalence Studies for Orally Adminis-tered Drug Products? General Considerations, Rockville. Maryland: Center for Drug Evaluation Research, Food and Drug Administration
- Ki, F. Y. C., Liu, J. P., Wang, W. and Chow, S. C. (1995). The impact of outlying subjects on decision of bioequivalence, Journal of Biopharmaceutical Statistics, 5, 71-94 https://doi.org/10.1080/10543409508835099
- Liu, J. P. and Weng, C. S. (1991). Detection of outlying data in bioavailability / bioequivalence studies, Statistics in Medicine, 10, 1375-1389 https://doi.org/10.1002/sim.4780100906
- Metzler, C. M. and Huang, D. C. (1983). Statistical methods for bioavailability and bioequivalence, Clini-cal Research Practices and Drug Regulatory Affairs, 1, 109-132 https://doi.org/10.3109/10601338309024010
- Ramsay, T. and Elkum, N. (2005). A comparison of four different methods for outlier detection in bioe-quivalence studies, Journal of Biopharmaceutical Statistics, 15, 43-52 https://doi.org/10.1081/BIP-200040815
- Rodda, B. E. (1986). Bioequivalence of Solid Oral Dosage Forms, A presentation to the U. S. Food and Drug Administration Hearing on Bioequivalence of Solid Oral Dosage Forms, September 29-October 1, Pharmaceutical Manufacturers Association, Section Ⅲ, 12-15
- Wang, W. and Chow, S. C. (2003). Examining outlying subjects and outlying records in bioequivalence trials, Journal of Biopharmaceutical Statistics, 13, 43-56 https://doi.org/10.1081/BIP-120017725
피인용 문헌
- On Evaluation of Bioequivalence for Highly Variable Drugs vol.24, pp.6, 2011, https://doi.org/10.5351/KJAS.2011.24.6.1055